GlobeImmune Secures $15,000,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f9206fa2-9096-4de0-bdfa-0b17afcee0ca - Date
7/2/2014 - Company Name
GlobeImmune - Mailing Address
1450 Infinite Drive Louisville, CO 80027 USA - Company Description
GlobeImmune, Inc. (NASDAQ: GBIM), is a biopharmaceutical company pioneering the discovery, development and manufacturing of potent, targeted molecular immunotherapy products called Tarmogens for the treatment of cancer and infectious diseases. - Website
http://www.globeimmune.com - Transaction Type
IPO - Transaction Amount
$15,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC. - M&A Terms
